Strumento inattivo

Altre lingue IVERIC bio, Inc.

Azioni

ISEE

US46583P1021

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Iveric Bio - Astellas Receives Permanent J-code for IZERVAY for Geographic Atrophy	27/03
Loan for Acquisition of U.S. Ophthalmic R&D Company IVERIC bio, Inc. by Astellas Pharma Inc	29/09/23
Two-time Emmy Award-Winning Actor, Eric Stonestreet, Partners with Iveric Bio to Raise Awareness of Geographic Atrophy	21/09/23
IVERIC bio, Inc. Announces Positive 24-Month Topline Results from Phase 3 Study of IZERVAY? (avacincaptad pegol intravitreal solution) for Geographic Atrophy	19/09/23
Astellas Pharma Inc. - European Medicines Agency Accepts Iveric Bio's Marketing Authorization Application for Avacincaptad Pegol for Geographic Atrophy	18/08/23
European Medicines Agency Accepts Iveric Bio's Marketing Authorization Application for Avacincaptad Pegol for Geographic Atrophy	18/08/23
Iveric Bio Receives U.S. FDA Approval for IZERVAY? (avacincaptad pegol intravitreal solution), a New Treatment for Geographic Atrophy	05/08/23
IVERIC bio's Acquisition by Astellas Pharma Completed	12/07/23
Astellas Pharma Completes $5.9 Billion Acquisition of Iveric bio	12/07/23
Astellas Completes Acquisition of Iveric Bio	12/07/23
IVERIC bio, Inc.(NasdaqGS:ISEE) dropped from NASDAQ Composite Index	11/07/23
IVERIC bio, Inc.(NasdaqGS:ISEE) dropped from S&P Biotechnology Select Industry Index	11/07/23
IVERIC bio, Inc.(NasdaqGS:ISEE) dropped from S&P Global BMI Index	11/07/23
IVERIC bio, Inc.(NasdaqGS:ISEE) dropped from S&P TMI Index	11/07/23
Astellas US Holding, Inc. completed the acquisition of IVERIC bio, Inc. from BlackRock, Inc., Deep Track Capital, LP, The Vanguard Group, Inc. and others.	11/07/23
IVERIC bio, Inc.(NasdaqGS:ISEE) dropped from NASDAQ Biotechnology Index	10/07/23
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	05/07/23
IVERIC BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of IVERIC bio, Inc. - ISEE	15/06/23
Insider Sell: Iveric Bio	06/06/23
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(4)	05/06/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue IVERIC bio, Inc.

Azioni

ISEE

US46583P1021

Altre lingue

Filtri